Michael Bray - Concepedia

Author

Michael Bray

Novartis (Switzerland)

Also Known As

M Bray, MICHAEL A BRAY, MICHAEL A. BRAY, Michael A. Bray, Michael Bray, Palmas, Walter

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Novartis (Switzerland)Drugs for Neglected Diseases Initiative Office of the Chief Medical Examiner Swiss Tropical and Public Health Institute University of Basel

About

Michael Bray is an author at Novartis (Switzerland) specializing in medicine, pharmacology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	535
2	Natural Sciences	4	4	212
3	Biochemistry	2	2	171
4	Engineering	1	1	14
5	Health Sciences	1	1	24

Michael Bray

Publications

956

Citations

H-Index

Page 1

	Year	Citations
Fexinidazole – A New Oral Nitroimidazole Drug Candidate Entering Clinical Development for the Treatment of Sleeping Sickness Els Torreele, Bernadette Bourdin Trunz, David Tweats, PLoS neglected tropical diseases	2010	311
Antitrypanosomal Activity of Fexinidazole, a New Oral Nitroimidazole Drug Candidate for Treatment of Sleeping Sickness Marcel Kaiser, Michael Bray, Monica Cal, Antimicrobial Agents and Chemotherapy Bioorganic ChemistryAntiparasitic AgentSleeping SicknessPharmacotherapyAntimicrobial Chemotherapy	2011	153
Advances in immunopharmacology Michael Bray Trends in Pharmacological Sciences VaccinationImmunologyImmunochemistryComparative ImmunologyImmunotherapy	1982	113
Determination of an Optimal Dosing Regimen for Fexinidazole, a Novel Oral Drug for the Treatment of Human African Trypanosomiasis: First-in-Human Studies Antoine Tarral, Séverine Blesson, Olaf Valverde Mordt, Clinical Pharmacokinetics	2014	96
Textbook of immunopharmacology Michael Bray Trends in Pharmacological Sciences Autoimmune DiseaseImmunologyAutoimmunityImmunologic DiseaseImmunosuppression	1985	85
Retinoids are potent inhibitors of the generation of rat leukocyte leukotriene B4-like activity in vitro Michael Bray European Journal of Pharmacology InflammationAnti-inflammatoryMedicineLipid PeroxidationImmunology	1984	30
Synthesis and SAR of a novel, potent and structurally simple LTD4 antagonist of the quinoline class Andreas von Sprecher, Marc Gerspacher, A. Beck, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryNatural SciencesMedicineOrganic ChemistryChemistry	1998	27
Vitreous Humor Chemistry in Deaths Associated with Rapid Chilling and Prolonged Freshwater Immersion Michael Bray Journal of Forensic Sciences Electrolyte DisorderAquaculturePhysiologyInhibited GlycolysisPoisoning	1983	25
Leukotrienes reduce nociceptive responses to bradykinin Alfred Schweizer, R. Brom, Markus Glatt, European Journal of Pharmacology Nociceptive ResponsesHealth SciencesPain MedicineMedicinePhysiology	1984	24
Platelet activating factor (PAF) is a potent stimulator of porcine tracheal fluid secretion in vitro Jürg Steiger, Michael Bray, N. Subramanian European Journal of Pharmacology InflammationPulmonary CirculationPhysiologyPotent StimulatorMedicine	1987	19

Page 1